Label: EXCELDERMA- wound cream cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 1, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • DOSAGE & ADMINISTRATION

    Clean the affected area. Apply Xcellderma. Reapply after 24 hours.

  • WARNINGS

    Warnings: External use only. Avoid contact with eyes. Not to be applied over deep or puncture wounds, infections or lacerations. If condition worsens or does not improve within 7 days, stop use and consult a doctor.

  • INDICATIONS & USAGE

    Indications: To cover and protect abrasions, skin tears, pressure ulcers and minor burns.

  • INACTIVE INGREDIENT

    Inactive ingredients: Polyethylene Glycol 4000, Polyethylene Glycol 400, Water, Citric Acid, Potassium Citrate, Benzoic Acid, Rubidium Chloride, Calcium Chloride.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.

  • PURPOSE

    To serve as a wound protectant

  • PRINCIPAL DISPLAY PANEL

    XCELLDERMA LIQUID BANDAGE/SKIN PROTECTANT

  • INGREDIENTS AND APPEARANCE
    EXCELDERMA 
    wound cream cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84076-111
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ZINC ACETATE (UNII: FM5526K07A) (ZINC CATION - UNII:13S1S8SF37) ZINC ACETATE0.001 g  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    CALCIUM CHLORIDE ANHYDROUS (UNII: OFM21057LP)  
    RUBIDIUM CHLORIDE (UNII: N3SHC5273S)  
    ZINC CHLORIDE (UNII: 86Q357L16B) 0.002 g  in 1 g
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    WATER (UNII: 059QF0KO0R)  
    POTASSIUM CITRATE ANHYDROUS (UNII: 86R1NVR0HW)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    POLYETHYLENE GLYCOL 4000 (UNII: 4R4HFI6D95)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84076-111-0130 g in 1 TUBE; Type 0: Not a Combination Product03/01/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01603/01/2024
    Labeler - Regenerex Pharma INC (119109997)
    Establishment
    NameAddressID/FEIBusiness Operations
    DGH Pharma INC128884560manufacture(84076-111)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!